Sponsored By
Industry, regional funding and support organizations, the region’s university system and local and state government entities recognize this workforce challenge...
Read more
Adaptive Phage Therapeutics, Inc. (“APT”), a clinical-stage biotechnology company advancing the world’s largest therapeutic phage initiative for treatment of bacterial...
The Maryland Stem Cell Research Commission announced it will grant $4,165,325 in award funding to innovative research that will strengthen and advance stem...
Adaptive Phage Therapeutics Awarded Additional $5 Million from U.S. Defense Health Agency to Support Diabetic Foot Osteomyelitis Clinical Trial (Photo:...
Baltimore company raises $19.4M to change the treatment of brain diseases Email Facebook LinkedIn Twitter Share article Deborah Weidman is...
